Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Guedan

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2010
Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growthSonia Guedan, Juan José Rojas, Alena Gros, et al.
Frontiers in Immunology|July 7, 2020
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor EscapeAlba Rodriguez-Garcia, Asis Palazon, Estela Noguera-Ortega, et al.
Cancer Research|November 1, 2008
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potencyAlena Gros, Jordi Martínez-Quintanilla, Cristina Puig, et al.
ACS Applied Materials & Interfaces|March 5, 2025
Lymph-Node Inspired Hydrogels Enhance CAR Expression and Proliferation of CAR T CellsMiquel Castellote-Borrell, Marc Domingo, Francesca Merlina, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2010
Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenovirusesJuan J Rojas, Sonia Guedan, Peter F Searle, et al.
Cancer Research|February 2, 2017
Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor EfficacyCarlos Alberto Fajardo, Sonia Guedan, Luis Alfonso Rojas, et al.
The Journal of Clinical Investigation|February 19, 2020
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durabilitySonia Guedan, Aviv Madar, Victoria Casado-Medrano, et al.
Cancer Immunology Research|March 29, 2018
Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell EngagerAnna Wing, Carlos Alberto Fajardo, Avery D Posey, et al.
Blood|July 3, 2014
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cellsSonia Guedan, Xi Chen, Aviv Madar, et al.
JCI Insight|February 23, 2018
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12Mireia Uribe-Herranz, Kyle Bittinger, Stavros Rafail, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2010
Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growthSonia Guedan, Juan José Rojas, Alena Gros, et al.
Frontiers in Immunology|July 7, 2020
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor EscapeAlba Rodriguez-Garcia, Asis Palazon, Estela Noguera-Ortega, et al.
Cancer Research|November 1, 2008
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potencyAlena Gros, Jordi Martínez-Quintanilla, Cristina Puig, et al.
ACS Applied Materials & Interfaces|March 5, 2025
Lymph-Node Inspired Hydrogels Enhance CAR Expression and Proliferation of CAR T CellsMiquel Castellote-Borrell, Marc Domingo, Francesca Merlina, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2010
Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenovirusesJuan J Rojas, Sonia Guedan, Peter F Searle, et al.
Cancer Research|February 2, 2017
Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor EfficacyCarlos Alberto Fajardo, Sonia Guedan, Luis Alfonso Rojas, et al.
The Journal of Clinical Investigation|February 19, 2020
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durabilitySonia Guedan, Aviv Madar, Victoria Casado-Medrano, et al.
Cancer Immunology Research|March 29, 2018
Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell EngagerAnna Wing, Carlos Alberto Fajardo, Avery D Posey, et al.
Blood|July 3, 2014
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cellsSonia Guedan, Xi Chen, Aviv Madar, et al.
JCI Insight|February 23, 2018
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12Mireia Uribe-Herranz, Kyle Bittinger, Stavros Rafail, et al.
Pageof 4